Navigation Links
GeoVax's DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
Date:10/20/2008

ATLANTA, Oct. 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based biotechnology company, developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today it has shipped both DNA and MVA components of its AIDS vaccine to the HIV Vaccine Trials Network (HVTN) pharmacy, for use in the upcoming Phase 2a human clinical trial. This Phase 2a study will involve 150 vaccinees and 75 placebo (control) participants. These trials serve as a major milestone, as Phase 2a trials are the most advanced trials to-date for GeoVax.

Dr. Robert McNally, President and CEO of GeoVax Labs Inc., commented, "The shipment of the vaccine to the HIV Vaccine Trials Network is a significant step in preparation for the largest clinical trial yet to be undertaken by GeoVax. Multiple completed Phase 1 safety trials refined the dose and vaccine delivery intervals to optimize the immune responses considered desirable to achieve protection against the HIV-1 virus causing AIDS."

Further, a Biological Master File has been submitted to the Food and Drug Administration (FDA) for review of the manufacturing data for the product shipped to HVTN for use in the Phase 2a trial. The FDA completes its review within four weeks. Upon FDA clearance, HVTN's pharmacy will release GeoVax's DNA and MVA vaccines for its planned Phase 2a trial commencement.

GeoVax AIDS vaccines are designed to prevent development of Acquired Immunodeficiency Disease (AIDS) caused by the virus known as HIV-1 by vaccinating individuals prior to virus infection. The vaccine regimen employs a two component "prime-boost strategy." Trial participants are first administered GeoVax HIV-1 DNA vaccine which "primes" the immune system followed by the second vaccine, GeoVax's HIV-1 MVA (Modified Vaccinia Virus) boost. Both vaccines express the 3 major proteins of the AIDS virus. These proteins mimic more than 50% of the
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
2. CDC Immunization Advisory Committee Recommends Two New Pediatric Vaccines from GlaxoSmithKline
3. Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today
4. Nanoemulsion vaccines show increasing promise
5. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
6. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
7. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
8. Emergence of Cancer Vaccines Will Be the Key Factor Driving the Pancreatic Cancer Drug Market to More Than Double by 2016
9. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
10. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
11. GeoVax Presents Data at AIDS Vaccine 2008 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , Mar. 04, 2015 Research and ... the addition of the "Global Biologics and ... offering. , The Global Biologics ... and in-depth study on the current state of ... report provides a basic overview of the industry ...
(Date:3/4/2015)... March 4, 2015  BioClinica®, Inc., a ... provider, today announced that clinical trial professionals ... at its annual European User Conference in ... discuss the use of its eClinical technologies ... technologies include: the Microsoft Office-Smart OnPoint CTMS; ...
(Date:3/4/2015)... March 4, 2015   ... für Diagnostik und Therapie, Strahlendosismanagement und IT-Lösungen für ... Royal Philips (NYSE: PHG, AEX: PHIA) ... 2015 (ECR) bekannt, der vom 4. bis 8. März ... den Ständen Nr. 102 and 110 ...
(Date:3/3/2015)... , March 3, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... million.  The orders are for odour control projects in ... and Asia . "Bidding activity in ... President and CEO. "After a high volume year for bidding in ... the New Year.  The recent orders reflect the organization,s renewed focus ...
Breaking Biology Technology:Global Biologics and Biosimilars Industry Report 2015-2020 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6
... Corp. (OTC Bulletin Board: BSTC), a biopharmaceutical company,developing ... President, Thomas Wegman, will present at the upcoming ... December 2, 2008, at,4:30pm ET at the New ... A live ...
... At a meeting of the Board,of Directors of Wyeth (NYSE: ... cents($0.50) per share on the outstanding shares of Preferred Stock ... at the close of business,on December 12, 2008. , ... world,s largest research-driven pharmaceutical and,health care products companies. It ...
... ORCHARD PARK, N.Y., Nov. 20 MINRAD International, Inc. (Amex: ... its workforce by approximately 35% or 50 positions. , ... Chief Operating Officer, said, "We have taken this difficult, but ... cash in response to our current adverse financial condition as ...
Cached Biology Technology:MINRAD International, Inc. Announces Reduction in Workforce 2
(Date:2/24/2015)... YORK , Feb. 24, 2015 This report analyzes ... by the following Segments: Face Biometrics, and Voice Biometrics. The report ... , Japan , Europe , ... & Africa , and Latin America ... 2013 through 2020. Also, a seven-year historic analysis is provided for ...
(Date:2/23/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND ... new groundbreaking payment method. Payment accounts may be selected ... be accessed if both the speech (the word associated ...
(Date:2/18/2015)...  Cepheid (NASDAQ: CPHD ) today announced that ... invited investors to participate via webcast. , Cowen and ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern Time ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern ... webcasts for these events, please visit Cepheid,s website at ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3Cepheid to Webcast Upcoming Financial Presentations 2
... Featured in the Biggest Government IT Security Event in ... ... (OTC,Bulletin Board: TTNUF), a leading biometric and security solutions provider,announced today that ... key vendors to showcase their products and technologies in the,Biometric and Identity ...
... with microscopic chambers, researchers from four institutions, including ... how bacteria survive in hostile environments by forming ... roles in cystic fibrosis, urinary tract infections and ... could help in the development of new treatments ...
... modifications to their successful wastewater fuel cell, researchers have ... efficient way. Bruce Logan and colleagues at Penn ... to produce electricity. Now, using starter material that could ... have coaxed those same microbes to generate hydrogen. ...
Cached Biology News:Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 2Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 3Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 4Together we stand: bacteria organize to survive hostile zones 2Together we stand: bacteria organize to survive hostile zones 3Microbes churn out hydrogen at record rate 2
Designed for use with all 96-well SPRI reagent kits. Used with round bottom 96-well microplates, and 96-well thermal cycling plates....
... modular, computer controlled pre-amplifier suitable for a ... electrode input for recording physiological signal such ... a transducer input for use with a ... Additional options include a stimulus artefact clamp ...
... be used with all 96-well ... stacking of covered plates ... with automated systems ... are available for use with ...
... for use with 96- or 384-well PCR plates ... of location on 96-tube plates End tabs on ... the plate* Efficient sealing is achieved with either ... screw or clip-down hot lid thermal cyclers Fully ...
Biology Products: